# Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases

> **NCT02759783** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 245 (actual)

## Conditions studied

- Prostate Cancer
- Breast Cancer
- Carcinoma, Non-Small-Cell Lung

## Interventions

- **RADIATION:** SBRT
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT02759783
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02759783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02759783, "Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02759783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*